ϳԹ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ϳԹ News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, May 5 2016

Full Issue

Fatal Flaws Of OxyContin Offer New Insight Into Addiction

An investigation by the Los Angeles Times finds that the 12-hour-relief promise of OxyContin, one of the most abused pharmaceuticals in U.S. history, doesn't hold true for some people. The problem, though, is that leads to withdrawal symptoms, and when the agony is relieved by the next dose, it creates a cycle of pain and euphoria that fosters addiction.

The drugmaker Purdue Pharma launched OxyContin two decades ago with a bold marketing claim: One dose relieves pain for 12 hours, more than twice as long as generic medications. Patients would no longer have to wake up in the middle of the night to take their pills, Purdue told doctors. One OxyContin tablet in the morning and one before bed would provide “smooth and sustained pain control all day and all night.” On the strength of that promise, OxyContin became America’s bestselling painkiller, and Purdue reaped $31 billion in revenue. But OxyContin’s stunning success masked a fundamental problem: The drug wears off hours early in many people, a Los Angeles Times investigation found. (Ryan, Girion and Glover, 5/5)

Meanwhile a panel of advisers says the Food and Drug Administration should change its risk-management programs for opioid painkillers and the U.S. surgeon general speaks about the worsening epidemic —

Dozens of advisers to the Food and Drug Administration on Wednesday unanimously called for the agency to rethink its approach to opioid abuse amid a worsening epidemic nationwide. (Ferris, 5/4)

Doctors who prescribe painkillers should be required to undergo training aimed at reducing misuse and abuse of the medications, according to federal health experts, though they acknowledge the challenge of putting such a mandate in place. The group of advisers to the Food and Drug Administration voted unanimously Wednesday that the agency should change its risk-management programs for opioid painkillers, highly addictive medications at the center of a national epidemic of addiction and abuse. (Perrone, 5/4)

U.S. Surgeon General Vivek Murthy on Wednesday called for more robust training for doctors who prescribe opioids, highlighting the medical community's role in combatting addiction. (Ferris, 5/4)

And media outlets report on the crisis in the states —

A bill aimed at tackling the epidemic of opioid and heroin abuse won final passage in the Senate Tuesday night. It now goes to Gov. Dannel P. Malloy, who plans to sign it. (Levin Becker, 5/4)

Say you suspect your loved one is using heroin or some other opioid and you’re worried about them overdosing. If a new bill making its way through the state legislature becomes law, you’ll be able to walk into any pharmacy in the state and get access to a drug that blocks opiate overdoses. (Hoban, 5/4)

Seattle police say bicycle officers have saved three people from potentially fatal heroin overdoses since they started carrying an overdose-reversal drug in mid-March. (5/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, June 8
  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ϳԹ
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF